The difference between the formal and the functional dose: the case of the patient on thioridazine and fluvoxamine.
Preskorn
Sheldon H
SH
Department of Psychiatry, University of Kansas School of Medicine, Wichita, KS, USA.
D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D005260:Female; D016666:Fluvoxamine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008607:Intellectual Disability / Q000150:complications*; D012559:Schizophrenia / Q000150:complications* / Q000188:drug therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D013881:Thioridazine / Q000008:administration & dosage / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D016666:Fluvoxamine; D017367:Selective Serotonin Reuptake Inhibitors; D013881:Thioridazine